|
|
|||
|
Noonan Syndrome is an autosomal dominant disorder characterized by short stature, webbed neck and dysmorphic facial features including hypertelorism, downward slanting palpebral fissures and posteriorly rotated ears. A variety of congenital cardiac anomalies are also associated with Noonan Syndrome. Other manifestations include shield chest with pectus deformities, vertebral anomalies, bleeding diathesis and cryptorchidism in males. Noonan syndrome is genetically heterogeneous, with mutations in the PTPN11 gene accounting for approximately 50% of both familial and sporadic cases. The PTPN11 gene maps to chromosome 12q24.1 and encodes the non-receptor protein tyrosine phosphatase SHP-2. Diagnostic sequence analysis of PTPN11 coding region is available for patients with Noonan syndrome. Reasons for Referral:
Testing Methodology:The PTPN11 gene coding region which contains fifteen exons is amplified by PCR, and direct sequencing is performed in both the forward and reverse directions using automated fluorescence dideoxy sequencing methods in a capillary electrophoresis format. Sensitivity:Technical: ~99% detection of mutations when present Specimen Requirements:Blood: EDTA (purple-top) tubes: Adults: 14
cc; Child: 6 cc; Infant: 2-3 cc Turnaround Time:4 weeks CPT Codes and Prices:Index: 83904x15, 83909x30, 83898x10,
83894, 83891 References:1. Tartaglia M, et al. (2002) Nat. Genet. 29: 465-468. Shipping InformationForms: >> Gene
Sequencing Requisition Test Codes:Index: 6065 |